214 related articles for article (PubMed ID: 10945504)
1. Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid.
Hinnen P; de Rooij FW; Terlouw EM; Edixhoven A; van Dekken H; van Hillegersberg R; Tilanus HW; Wilson JH; Siersema PD
Br J Cancer; 2000 Aug; 83(4):539-43. PubMed ID: 10945504
[TBL] [Abstract][Full Text] [Related]
2. Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.
Hinnen P; de Rooij FW; van Velthuysen ML; Edixhoven A; van Hillegersberg R; Tilanus HW; Wilson JH; Siersema PD
Br J Cancer; 1998 Sep; 78(5):679-82. PubMed ID: 9744510
[TBL] [Abstract][Full Text] [Related]
3. Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus.
Hinnen P; de Rooij FW; Hop WC; Edixhoven A; van Dekken H; Wilson JH; Siersema PD
J Photochem Photobiol B; 2002 Aug; 68(1):8-14. PubMed ID: 12208031
[TBL] [Abstract][Full Text] [Related]
4. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
5. Two course illuminating scheme improves aminolevulinic acid photodynamic therapy in cell cultures.
Hinnen P; Siersema PD; Edixhoven A; Wilson JH; de Rooij FW
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):903-9. PubMed ID: 12699249
[TBL] [Abstract][Full Text] [Related]
6. Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus.
van den Boogert J; Houtsmuller AB; de Rooij FW; de Bruin RW; Siersema PD; van Hillegersberg R
Lasers Surg Med; 1999; 24(1):3-13. PubMed ID: 10037346
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia.
Tan WC; Fulljames C; Stone N; Dix AJ; Shepherd N; Roberts DJ; Brown SB; Krasner N; Barr H
J Photochem Photobiol B; 1999; 53(1-3):75-80. PubMed ID: 10672532
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.
Ackroyd R; Brown N; Vernon D; Roberts D; Stephenson T; Marcus S; Stoddard C; Reed M
Photochem Photobiol; 1999 Oct; 70(4):656-62. PubMed ID: 10546561
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus.
Dunn J; Lovat L
Expert Opin Pharmacother; 2008 Apr; 9(5):851-8. PubMed ID: 18345960
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Pech O; Nagy CD; Gossner L; May A; Ell C
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):657-62. PubMed ID: 12072600
[TBL] [Abstract][Full Text] [Related]
11. A regulatory role for porphobilinogen deaminase (PBGD) in delta-aminolaevulinic acid (delta-ALA)-induced photosensitization?
Gibson SL; Cupriks DJ; Havens JJ; Nguyen ML; Hilf R
Br J Cancer; 1998; 77(2):235-42. PubMed ID: 9460994
[TBL] [Abstract][Full Text] [Related]
12. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Hua Z; Gibson SL; Foster TH; Hilf R
Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
15. Delta-aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro.
Gibson SL; Havens JJ; Nguyen ML; Hilf R
Br J Cancer; 1999 Jun; 80(7):998-1004. PubMed ID: 10362107
[TBL] [Abstract][Full Text] [Related]
16. Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus.
Kelty CJ; Ackroyd R; Brown NJ; Brown SB; Reed MW
Surg Endosc; 2004 Mar; 18(3):452-8. PubMed ID: 14752635
[TBL] [Abstract][Full Text] [Related]
17. Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells.
Messmann H; Geisler M; Gross U; Abels C; Szeimies RM; Steinbach P; Knüchel R; Doss M; Schölmerich J; Holstege A
Br J Cancer; 1997; 76(7):878-83. PubMed ID: 9328146
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus.
Claydon PE; Ackroyd R
Dis Esophagus; 2004; 17(3):205-12. PubMed ID: 15361092
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.
Barr H
Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):421-37. PubMed ID: 10899256
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
